CMV neurologic disease: Difference between revisions

No edit summary
 
Line 14: Line 14:
**[[Paresthesia]], distal [[numbness|sensory loss]]
**[[Paresthesia]], distal [[numbness|sensory loss]]
**[[Urinary retention]]
**[[Urinary retention]]
**Ascending [[weakness|paralysis]], similar to [[Guillan-Barre]]
**Ascending [[weakness|paralysis]], similar to [[Guillain-Barre]]


==Differential Diagnosis==
==Differential Diagnosis==

Latest revision as of 00:35, 3 October 2019

Background

Clinical Features[1]

Differential Diagnosis

Altered mental status and fever

HIV associated conditions

Evaluation

  • Neuroimaging (MRI more helpful than CT)
  • CMV PCR

Management

Antivirals

  • Ganciclovir 5mg/kg IV q12hrs x 21 days then 5mg/kg IV q24hrs +
    • Foscarnet 90mg/kg IV q12hrs x 21 days then 90-120mg/kg IV q24hrs

Disposition

  • Admit

See Also

External Links

References

  1. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545043/all/CMV__neurologic
  2. Gutteridge, David L MD, MPH, Egan, Daniel J. MD. The HIV-Infected Adult Patient in The Emergency Department: The Changing Landscape of the Disease. Emergency Medicine Practice: An Evidence-Based Approach to Emergency Medicine. Vol 18, Num 2. Feb 2016.